RecruitingPhase 1

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT07219511

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Cardiology and Medicine Clinic

Little Rock, Arkansas, United States

+20 additional locations

Contact

Clinical Team

Save this trial

Cardiology and Medicine ClinicLittle Rock, Arkansas, United States
National Institute of Clinical ResearchHuntington Beach, California, United States
FOMATSanta Maria, California, United States
Invivocure LLCVan Nuys, California, United States
New Generation of Medical ResearchHialeah, Florida, United States
Jacksonville Center for Clinical ResearchJacksonville, Florida, United States
Amavita HealthNorth Miami Beach, Florida, United States
Broward Research CenterPembroke Pines, Florida, United States
Eagle Clinical ResearchChicago, Illinois, United States
Chicago Medical ResearchHazel Crest, Illinois, United States
Methodist Medical Center of IllinoisPeoria, Illinois, United States
Louisiana Heart CenterSlidell, Louisiana, United States
Washington UniversitySt Louis, Missouri, United States
Ash Research ClinicBrick, New Jersey, United States
Erie County Medical CenterBuffalo, New York, United States
Duke University Medical CenterDurham, North Carolina, United States
Wake ForestWinston-Salem, North Carolina, United States
Cleveland ClinicCleveland, Ohio, United States
Oklahoma Heart HospitalOklahoma City, Oklahoma, United States
University of Texas Southwestern Medical CenterDallas, Texas, United States
LinQ Research, LLCTomball, Texas, United States